Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

The FDA is warning the public about a drug rising in popularity commonly referred to as as "gas station heroin." ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Given the complexity of controlled substance regulations, organizations must take a proactive approach to compliance and ...

This marks a shift in the agency's approach to treating the global obesity problem. Read more at straitstimes.com. Read more ...